Company Profiles

driven by the PitchBook Platform

Aelis Farma

Description

Developer of signaling specific therapeutics designed for the treatment of cannabis abuse. The company's signaling specific therapeutics specializes in the development of first-in-class CB1 (cannabinoid receptor) signaling specific inhibitors targeting cannabis abuse, enabling physicians to provide proper feedback on treatment progress.

2013

Founded

PRIVATE

Status

1-10

Employees

Grant

Latest Deal Type

$561k

Latest Deal Amount

$2.07M

Total Amount Raised

Description

Developer of signaling specific therapeutics designed for the treatment of cannabis abuse. The company's signaling specific therapeutics specializes in the development of first-in-class CB1 (cannabinoid receptor) signaling specific inhibitors targeting cannabis abuse, enabling physicians to provide proper feedback on treatment progress.

Website:

www.aelisfarma.com

Ownership Status

Privately Held (backing)

Financing Status

Venture Capital-Backed

Primary Industry

Biotechnology

Other Industries

Pharmaceuticals
Drug Discovery

Primary Office

Institut François Magendie 146, rue Léo Saignat 33077 BordeauxFrance +33 (0)5 57 57 36 62
Request a free trial to the PitchBook Platform
You're viewing a free company profile from the PitchBook Platform. To explore Aelis Farma's full profile, request a free trial.

Aelis Farma Valuation and Funding

Request access
Deal TypeDateAmountRaised to DatePost-ValStatusStage

Aelis Farma Investors (6)

Request access
Investor NameInvestor TypeHoldingInvestor SinceParticipating RoundsBoard
Seat
Contact
Info
Aqui-InvestOtherMinority000 0000000 0000
AQUITI GestionVenture CapitalMinority000 0000000 0000
BpifranceOtherMinority000 0000000 0000
European CommissionGovernment000 0000000 0000
Inserm Transfert InitiativeVenture CapitalMinority000 0000000 0000
Aqui-Invest Other
AQUITI Gestion Venture Capital
Bpifrance Other
European Commission Government
Inserm Transfert Initiative Venture Capital

Aelis Farma Executive Team (5)

NameTitleBoard
Seat
Contact
Info
Valérie ScappaticciCo-Founder, Chief Executive Officer & President
Pier Piazza Ph.DCo-Founder & Director, Research & Development
Sandy Fabre Ph.DCo-Founder & Head of Chemistry and Pharmaceutical development
Stéphanie Monlezun Ph.DCo-Founder & Head of Project Management
Giovanni Marsicano Ph.DCo-Founder
Valérie Scappaticci Co-Founder, Chief Executive Officer & President
Pier Piazza Ph.D Co-Founder & Director, Research & Development
Sandy Fabre Ph.D Co-Founder & Head of Chemistry and Pharmaceutical development
Stéphanie Monlezun Ph.D Co-Founder & Head of Project Management
Giovanni Marsicano Ph.D Co-Founder

Aelis Farma Board Members (1)

NameRepresentingRoleSinceContact
Info
Matthieu CoutetSelfBoard Member000 0000
Matthieu Coutet Board Member Self
Request full access to PitchBook